Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 8, 2010, Pages 1143-1150

  Wakui, M ^a   Yokoyama, Yoshihito ^a   Wang, H ^a   Shigeto, T ^a   Futagami, M ^a   Mizunuma, H ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Anti angiogenesis; Apoptosis; Methyl ester of 5 aminolevulinic acid; Ovarian cancer; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; CD34 ANTIGEN; LACTADHERIN; PHOSPHATE BUFFERED SALINE; PROTOPORPHYRIN; VASCULOTROPIN; AMINOLEVULINIC ACID; DELTA AMINOLEVULINIC ACID METHYL ESTER; DELTA-AMINOLEVULINIC ACID METHYL ESTER; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TREATMENT DURATION; TUMOR XENOGRAFT; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; CELL DIVISION; DISEASE MODEL; DRUG EFFECT; METHODOLOGY; NECROSIS; OVARY TUMOR; PATHOLOGY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, NUDE; NECROSIS; OVARIAN NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 77954590350     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0761-7     Document Type: Article

References (21)

1. Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776:86-107
2. Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1. Photochemistry and photobiology. J Eur Acad Dermatol Venereol 21:293-302
3. Casas A, Venosa GD, Vanzulli S, Perotti C, Mamome L, Rodriguez L, Simian M, Juarranz A, Pontiggia O, Hasan T, Batlle A (2008) Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy. Cancer Lett 271:342-351
4. Chu ESM, Yow CMN, Shi M, Ho RJY (2008) effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine carcoma cells. Toxicol Lett 181:7-12
5. Doughetry TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905 (Pubitemid 28304157)
6. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) IdentiWcation of programmed cell death in situ via speciWc labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
7. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S (2002) IdentiWcation of a factor that links apoptotic cells to phagocytosis. Nature 417:182-187
8. Kaiser PK (2007) VerteporWn photodynamic therapy and antiangiogenic drugs: pontential for combination therapy in exudative age-related macular degeneration. Curr Med Res Opin 23:477-487
9. Kiesslich T, Plaetzer K, Oberdanner CB, Berlanda J, Obermair FJ, Krammer B (2005) DiVerential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction. FEBS Lett 579:185-190
10. Manivasager V, Yee KKL, Heng PWS, Soo KC, Olivo M (2006) A study comparing endogenous protoporphyrin IX induced by 5- ALA and ALA-methyl ester with exogenous PpIX and PpIX dimethyl ester photodynamic diagnosis of human nasopharyngeal carcinoma xenografts. Int J Oncol 29:997-1002
11. McGuire WP, Hoskins WJ, Brady MF, Kurera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1-6
12. Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giereksky K-E, Nesland JM (2001) Antitumor effect of 5-aminolevulinic acidmediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res 61:5824-5832
13. Sakamoto A, Yokoyama Y, Umemoto M, Futagami M, Sakamoto T, Xin B, Mizunuma H (2004) Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor in epithelial ovarian tumours. Br J Cancer 91:633-638
14. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ (2000) Global, regional estimates of cacer mortality, incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2:37
15. Shimada M, Kigawa J, Ohishi Y, Yasuda M, Suzuki M, Hiura M, Nishimura R, Tabata T, Sugiyama T, Kaku T (2009) Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Gynecol Oncol 113:331-334
16. Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, Suzuki M, Sato I, Taguchi K (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584-2589
17. Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T (2006) Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 94:1369-1374
18. Tsai T, Hong RL, Tsai JL, Lou PJ, Ling IF, Chen CT (2004) effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF- 7 and MCF-7/ADR cells. Lasers Surg Med 34:62-72
19. Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y (2001) Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 85:1032-1036
20. Volanti C, Gloire G, Vanderplasshen A, Jacobs N, Habraken Y, Piette J (2004) Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23:8649-8658
21. Yokoyama Y, Sakamoto T, Sato S, Saito Y (1999) Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Eur J Gynaecol Oncol 20:361-366